Expanded Access for Treatment With Imetelstat
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
- Status
- TERMINATED
- Phase
- PHASE1
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD
- Status
- RECRUITING
- Phase
- PHASE2
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
- Status
- RECRUITING
- Phase
- NA
Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- N/A
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Telehealth Advance Care Planning Intervention
- Status
- RECRUITING
- Phase
- NA
A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Allo HSCT Using RIC and PTCy for Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
- Status
- RECRUITING
- Phase
- PHASE2
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Cladribine and Low-Dose Cytarabine (LoDAC) Alternating With Decitabine vs. Hypomethylating Agents (HMA) Plus Venetoclax as Frontline Therapy for AML or High-Grade MDS in Patients Unfit for Intensive Induction
- Status
- WITHDRAWN
- Phase
- PHASE2
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Status
- RECRUITING
- Phase
- NA
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2